Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176878 · ClinicalTrials.gov registry record · Phase 2
Stem Cell Transplant for Bone Marrow Failure Syndromes
A Phase 2 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00176878: Completed Phase 2 study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT00176878 is a Phase 2 study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176878, a Phase 2 study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The researchers hypothesize that it will be possible to perform unrelated bone marrow or cord blood transplants in a safer manner by using less intensive therapy yet still achieve an acceptable level of donor cell engraftment for non-malignant congenital bone marrow failure disorders.
Primary Outcome
Calculated from day 1 of transplant to last contact.
Interventions
- DRUG Busulfan
- BIOLOGICAL anti-thymocyte globulin
- DRUG Fludarabine monophosphate
- PROCEDURE Total lymphoid irradiation
- PROCEDURE Stem cell transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
What the finished NCT00176878 record still lists
NCT00176878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which Busulfan is the first listed.
NCT00176878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00176878 about?
NCT00176878 is a clinical study titled "Stem Cell Transplant for Bone Marrow Failure Syndromes". The researchers hypothesize that it will be possible to perform unrelated bone marrow or cord blood transplants in a safer manner by using less intensive therapy yet still achieve an acceptable level of donor cell engraftment for non-malignant congenital bone marrow failure disorders.
What is the current status of trial NCT00176878?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2000-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00176878?
The interventions under investigation include: Busulfan (DRUG), anti-thymocyte globulin (BIOLOGICAL), Fludarabine monophosphate (DRUG), Total lymphoid irradiation (PROCEDURE), Stem cell transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00176878?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00176878's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia